40
Participants
Start Date
April 30, 2013
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
RBP-8000 100 mg
RBP-8000 100 mg administered in the vein on either study day 3 or 6. There is a 72-hour washout between Days 3 and 6
Placebo
IV infusion of Placebo administered 1 minute after cocaine infusion on either day 3 or 6.
Cocaine
50 mg intravenous (IV) dose of cocaine administered over 10 minutes on Days 1, 3 and 6.
RBP-8000 200 mg
RBP-8000 200 mg administered in the vein on either study day 3 or 6. There is a 72-hour washout between Days 3 and 6
Vince and Associates Clinical Research, Overland Park
Lead Sponsor
Indivior Inc.
INDUSTRY